Search Results - "Ghazalah, Hind"

Obesity diabetes and dyslipidemia as determinants of immune checkpoint inhibitors response in non-small cell lung cancer by Awidi, Muhammad, Osataphan, Soravis, Jan, Yu Jen, Frankenberger, Edward, Mariano, Melissa, Stafford, Katherine Ann, Kolnick, Aleksandra, Ghazalah, Hind, Patti, Mary-Elizabeth, Gunturu, Krishna Soujanya, Lam, Prudence B.

“…e21104 Background: Immune checkpoint inhibitors (ICI) are standard of care in the treatment of non-small cell lung cancer (NSCLC). Predictive markers of…”
Get full text

Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors by Osataphan, Soravis, Awidi, Muhammad, Jan, Yu Jen, Gunturu, Krishna, Sundararaman, Shriram, Viray, Hollis, Frankenberger, Edward, Mariano, Melissa, O’Loughlin, Lauren, Piper-Vallillo, Andrew, Stafford, Katherine, Kolnick, Aleksandra, Ghazalah, Hind, Sehgal, Kartik, Patti, Mary-Elizabeth, Costa, Daniel, Lam, Prudence, Rangachari, Deepa

“…•Obesity is known to be associated with improved outcomes in patients with NSCLC treated with ICIs.•In this multicenter retrospective cohort, higher mean…”
Get full text

Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer by Osataphan, Soravis Alm, Awidi, Muhammad, Jan, Yu Jen, Sundararaman, Shriram, Viray, Hollis, Frankenberger, Edward, Mariano, Melissa, Stafford, Katherine Ann, Kolnick, Aleksandra, Ghazalah, Hind, Patti, Mary-Elizabeth, Gunturu, Krishna Soujanya, Rangachari, Deepa, Costa, Daniel Botelho, Lam, Prudence B.

“…e21125 Background: Immune checkpoint inhibitors (IOs) are the standard of care in the treatment of advanced non-small cell lung cancer (NSCLC). Predictive…”
Get full text